Ganan-Gomez I, Yang H, Ma F, Montalban-Bravo G, et al. Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. Nat Med 2022 Mar 3. pii: 10.1038/s41591-022-01696.
PMID: 35241842